Niagen Bioscience (NAGE) EBT Margin Growth (5y) (2015 - 2026)
Niagen Bioscience (NAGE) EBT Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Niagen Bioscience |
280.11 Mn |
213.56 Mn |
19.98 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
7,167.00 |
| Dec 31, 2025 |
5,255.00 |
| Sep 30, 2025 |
4,385.00 |
| Jun 30, 2025 |
3,629.00 |
| Mar 31, 2025 |
5,822.00 |
| Dec 31, 2024 |
9,339.00 |
| Sep 30, 2024 |
6,709.00 |
| Jun 30, 2024 |
6,979.00 |
| Mar 31, 2024 |
8,110.00 |
| Dec 31, 2023 |
9,142.00 |
| Sep 30, 2023 |
10,105.00 |
| Jun 30, 2023 |
9,177.00 |
| Mar 31, 2023 |
11,984.00 |
| Dec 31, 2022 |
11,027.00 |
| Sep 30, 2022 |
3,156.00 |
| Jun 30, 2022 |
2,730.00 |
| Mar 31, 2022 |
15,441.00 |
| Dec 31, 2021 |
1,920.00 |
| Sep 30, 2021 |
-2,685.00 |
| Jun 30, 2021 |
-3,028.00 |
